IVT-8086

N/A

Report date: 2023/11/08 13:56:23

Base Information

Drug NameIVT-8086
Drug Alias NameIVT-8086
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAngiogenesis inhibitorsApoptosis stimulantsT lymphocytes stimulants +[4] 
TargetsSecreted frizzled-related protein 2
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnova Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnova Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A